Moderna Says FDA Advisory Committee Unanimously Backs mRNA-1010 Seasonal Flu Vaccine For Adults 50–64 and 65+, Voting 9-0 That Benefits Outweigh Risks Ahead Of August 5 PDUFA Decision Date

뉴스 본문을 불러오고 있어요.

Moderna Says FDA Advisory Committee Unanimously Backs mRNA-1010 Seasonal Flu Vaccine For Adults 50–64 and 65+, Voting 9-0 That Benefits Outweigh Risks Ahead Of August 5 PDUFA Decision Date | 웨이프 WAPE

Moderna Says FDA Advisory Committee Unanimously Backs mRNA-1010 Seasonal Flu Vaccine For Adults 50–64 and 65+, Voting 9-0 That Benefits Outweigh Risks Ahead Of August 5 PDUFA Decision Date

기사 요약

관련 종목

댓글 —